dspe-peg(2000)

DSPE-PEG(2000)-azide is a PEGylated derivative based on 1,2-distearoyl-sn-glycero-3-phosphoethanolamine (1,2-DSPE). This compound is utilized for attaching vascular cell adhesion molecule-1 (VCAM-1) antibodies to vesicles that encapsulate fingolimod, aiming to target the delivery of fingolimod to inflammatory vessels in mouse models simulating post-ischemic neuroinflammation. Additionally, DSPE-PEG(2000)-azide is employed to link fibrinogen mimetic peptides (FMP) to the surface of synthetic platelets used in treating uncontrollable bleeding caused by liver damage in mouse models.

DSPE-PEG(2000)-amine is a PEGylated derivative of 1,2-distearoyl-sn-glycero-3-PE . It has been used in the synthesis of solid lipid and thermosensitive liposomal nanoparticles for the delivery of anticancer agents.1,2,3DSPE-PEG(2000)-amine has also been used in the synthesis of fluorescein isothiocyanate-loaded mesoporous silica nanoparticles for imaging applications.4It can be conjugated to a variety of functional molecules for improved cellular targeting and uptake of DSPE-PEG(2000)-amine-containing nanoparticles.4,5 1.Sloat, B.R., Sandoval, M.A., Li, D., et al.In vitro and in vivo anti-tumor activities of a gemcitabine derivative carried by nanoparticlesInt. J. Pharm.409(1-2)278-288(2011) 2.Abd-Rabou, A.A., Bharali, D.J., and Mousa, S.A.Taribavirin and 5-fluorouracil-loaded pegylated-lipid nanoparticle synthesis, p38 docking, and antiproliferative effects on MCF-7 breast cancerPharm. Res.35(4)76(2018) 3.Affram, K., Udofot, O., Singh, M., et al.Smart thermosensitive liposomes for effective solid tumor therapy and in vivo imagingPLoS One12(9):e0815116(2017) 4.Wang, L.-S., Wu, L.-C., Lu, S.-Y., et al.Biofunctionalized phospholipid-capped mesoporous silica nanoshuttles for targeted drug delivery: Improved water suspensibility and decreased nonspecific protein bindingACS Nano4(8)4371-4379(2010) 5.Wen, X., Wang, K., Zhao, Z., et al.Brain-targeted delivery of trans-activating transcriptor-conjugated magnetic PLGA/lipid nanoparticlesPLoS One9(9):e106652(2014)

DSPE-PEG(2000)-mannose, a pegylated and mannosylated derivative of 1,2-DSPE, has been employed in both in vitro and in vivo studies for delivering peptides, oligodeoxynucleotides, and siRNA via liposomes and lipid nanoparticles (LNPs). Fluorescently labeled LNPs containing DSPE-PEG(2000)-mannose predominantly accumulate in the liver and spleen of mice, significantly more so than in the brain, lungs, heart, kidneys, and pancreas. In immunization studies, liposomes encapsulating Human Papillomavirus type 16 (HPV16) E7 peptides with CpG oligodeoxynucleotides as an adjuvant led to reduced tumor volume and decreased numbers of CD4+ or CD8+ T cells and angiogenesis within tumors in a mouse lung cancer model using TC-1 cells.

DSPE-PEG(2000)-COOH, a 1,2-distearoyl-sn-glycero-3-PE (DSPE) derivative modified by PEGylation and carboxylation, is a non-toxic and biodegradable amphiphilic copolymer that can be used to form micelles to deliver nanoparticles.

DSPE-PEG(2000)-Amine is a useful organic compound for research related to life sciences and the catalog number is T64566.

DSPE-PEG(2000)-N-Triphenylphosphonium is a functionalized PEG lipid utilized in the synthesis of lipid nanoparticles for drug delivery.

DSPE-PEG(2000)-square is a functionalized PEG lipid utilized in the synthesis of lipid nanoparticles for drug delivery.

DSPE-PEG(2000) Succinyl ammonium is a functionalized PEG lipid suitable for synthesizing lipid nanoparticles used in drug delivery.

DSPE-PEG 2000 is a non-toxic and biodegradable amphiphilic copolymer that can be used to form micelles to deliver nanoparticles.

DSPE-PEG Carboxylic Acid Sodium (MW 2000), a PEG-lipid, facilitates the formation of micelle nanoparticles for drug delivery and extends the blood circulation time of liposomes [1].

DSPE-MPEG2000 is a phospholipid–PEG conjugate possessing both hydrophilic and hydrophobic characteristics. DSPE-PEG(2000) is widely utilized in liposome formulation to enhance aqueous dispersion, surface hydration, and in vivo circulation time. DSPE-PEG(2000) supports the development of long-circulating liposomal drug-delivery systems and is frequently applied in preclinical studies involving anticancer and antimalarial therapeutic agents.

DSPE-PEG(2000)-TCO is a polyethylene glycol-modified derivative of DSPE for preparing lipid nanoparticles (LNPs), whose TCO moiety undergoes bioorthogonal IEDDA reactions with triazine rings.

DSPE-PEG(2000)-amine is a polyethylene glycol derivative of 1,2-Distearoyl-sn-glycero-3-phosphorylethanolamine, utilized in synthesizing solid lipid and thermosensitive liposome nanoparticles for cancer drug delivery.

DSPE-PEG-Maleimide features DSPE phospholipids and maleimide for the preparation of nano-structured lipid carriers. It enhances the stability of encapsulated active molecules and prolongs circulation time in the bloodstream.

DSPE-PEG2000-RVG29 is a PEG compound composed of DSPE and rabies virus glycoprotein 29 (RVG29). RVG29 specifically binds to nicotinic acetylcholine receptors (nAChR) at the blood-brain barrier (BBB) and can traverse the BBB.

DSPE-PEG2000-M2pep is a PEG compound formed from DSPE and the M2-polarized macrophage-targeting peptide (M2pep). M2pep acts as a monovalent or multivalent ligand conjugated with pro-apoptotic peptides to specifically target M2 macrophages with toxic effects. DSPE-PEG2000-M2pep is applicable for drug delivery.

DSPE-PEG2000-ANG is a PEG compound composed of DSPE and the dual-targeting ligand (Angiopep-2, ANG). ANG exhibits high binding efficiency to LRP1 and has been used for targeted delivery to gliomas. DSPE-PEG2000-ANG can be utilized in drug delivery applications.

DSPE-PEG2000-R8 is a PEGylated compound composed of DSPE and the cell-penetrating peptide (R8). It can be applied in drug delivery.

DSPE-PEG2000-LTLRWVGLMS is a PEG compound composed of DSPE and the decapeptide (LTLRWVGLMS). Chondroitin sulfate proteoglycan NG2 is the receptor for LLRWVGLMS. LLRWVGLMS demonstrates homing to pericytes associated with tumor vasculature. DSPE-PEG2000-LTLRWVGLMS can be utilized for drug delivery.

DSPE-PEG2000-TAASGVRSMH is a PEG compound composed of DSPE and TAASGVRSMH. This compound exhibits strong affinity for the NG2 proteoglycan on PC membranes. DSPE-PEG2000-TAASGVRSMH can be utilized for drug delivery.

DSPE-PEG2000-CSTSMLKAC is a PEG compound composed of DSPE and CSTSMLKAC. CSTSMLKAC can mediate phage selective homing to ischemic heart tissue. DSPE-PEG2000-CSTSMLKAC is suitable for drug delivery.

DSPE-PEG2000-CTT2 is a PEG compound consisting of DSPE and the gelatinase inhibitor CTT2 (CTTHWGFTLC). It possesses the ability to specifically target tumors. DSPE-PEG2000-CTT2 is suitable for drug delivery applications.

DSPE-PEG2000-A7R is a PEG compound consisting of DSPE and a tumor vasculature-targeting peptide (A7R). A7R exhibits high affinity and specificity for VEGFR-2, a receptor that is overexpressed in various tumors.

DSPE-PEG2000-CCK8 is a PEG compound comprising DSPE and Cholecystokinin-8 (CCK8). Cholecystokinin-8 exhibits peptide activity responsible for regulating gallbladder contractions and digestive system functions. DSPE-PEG2000-CCK8 is applicable for drug delivery.